Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chimera Antigen Receptor (CAR)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02903810
What this trial is testing

Combination Transfer of αCD19-TCRz-41BB and αCD22-TCRz-41BB CAR-T Cells for B-cell Hematologic Malignancy

Who this might be right for
Hematopoietic/Lymphoid Cancer
Xuzhou Medical University 20
Early research (Phase 1)Looking for participantsNCT07087002
What this trial is testing

GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults

Who this might be right for
MedulloblastomaCentral Nervous System Embryonal TumorRefractory Medulloblastoma+7 more
Stanford University 18
Early research (Phase 1)Looking for participantsNCT05625594
What this trial is testing

Intracerebroventricular Administration of CD19-CAR T Cells (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/Mem T-lymphocytes) for the Treatment of Central Nervous System Lymphoma

Who this might be right for
Central Nervous System Lymphoma
City of Hope Medical Center 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04146051
What this trial is testing

Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)

Who this might be right for
Myasthenia Gravis, Generalized
Cartesian Therapeutics 30
Early research (Phase 1)Looking for participantsNCT05887167
What this trial is testing

Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies

Who this might be right for
Hematologic MalignancyLarge B-cell LymphomaAcute Lymphoblastic Leukemia+3 more
Joshua Sasine, MD, PhD 20
Testing effectiveness (Phase 2)UnknownNCT04534634
What this trial is testing

Study of IFN-α Combined With CAR-T Cell Therapy in Relapsed and Refractory Acute Lymphoblastic Leukemia（R/R-ALL）

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University 60
Early research (Phase 1)Study completedNCT05182073
What this trial is testing

FT576 in Subjects With Multiple Myeloma

Who this might be right for
Multiple MyelomaMyeloma
Fate Therapeutics 31
Very early researchUnknownNCT03267173
What this trial is testing

Evaluate the Safety and Efficacy of CAR-T in the Treatment of Pancreatic Cancer.

Who this might be right for
Pancreatic CancerCAR
First Affiliated Hospital of Harbin Medical University 10
Early research (Phase 1)Active Not RecruitingNCT02932956
What this trial is testing

Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP)

Who this might be right for
Liver Cancer
Baylor College of Medicine 10
Early research (Phase 1)Looking for participantsNCT06056102
What this trial is testing

CAR-T Cell Therapy for Desensitization in Kidney Transplantation

Who this might be right for
Kidney TransplantKidney FailureEnd Stage Renal Failure on Dialysis
National Institute of Allergy and Infectious Diseases (NIAID) 20
Very early researchLooking for participantsNCT06999031
What this trial is testing

Evaluate CG-105-12 in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/RefractoryMultiple Myeloma
The First Affiliated Hospital of Nanchang University 12
Not applicableStudy completedNCT04026737
What this trial is testing

Cardiovascular Effects of CART Cell Therapy

Who this might be right for
LeukemiaLymphomaCardiotoxicity+2 more
Abramson Cancer Center at Penn Medicine 44
Very early researchUnknownNCT03943472
What this trial is testing

BCMA Chimeric Antigen Receptor Expressing T Cells Therapy for Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Hrain Biotechnology Co., Ltd. 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT07493395
What this trial is testing

Phase IIa Trial of Anti-CD19 CAR T-Cells in Systemic Sclerosis Resistant to Immunosuppressive Therapy

Who this might be right for
Scleroderma, Systemic
University Hospital, Montpellier 6
Early research (Phase 1)Looking for participantsNCT05949125
What this trial is testing

Phase 1 Study of Allo-RevCAR01-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies (1b Dose Expansion)

Who this might be right for
Acute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia Refractory
AvenCell Europe GmbH 37
Testing effectiveness (Phase 2)UnknownNCT03090659
What this trial is testing

LCAR-B38M Cells in Treating Relapsed/Refractory (R/R) Multiple Myeloma

Who this might be right for
Refractory or Relapsed Multiple Myeloma
Nanjing Legend Biotech Co. 100
Not applicableUnknownNCT02919046
What this trial is testing

Study Evaluating the Efficacy and Safety With CAR-T for Relapsed or Refractory Neuroblastoma in Children

Who this might be right for
Relapsed or Refractory Neuroblastoma
Sinobioway Cell Therapy Co., Ltd. 22
Early research (Phase 1)UnknownNCT02706782
What this trial is testing

Mesothelin Redirected Autologous T Cells for Advanced Pancreatic Carcinoma

Who this might be right for
Pancreatic Cancer
Shanghai GeneChem Co., Ltd. 30
Testing effectiveness (Phase 2)UnknownNCT03366350
What this trial is testing

Anti-CD19 CAR-T Therapy Bridging to HSCT for CD19+ B-Cell Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaB Cell Lymphoma
Wuhan Sian Medical Technology Co., Ltd 50
Early research (Phase 1)Looking for participantsNCT06972576
What this trial is testing

Clinical Study of Combined EphA2-targeted CAR-DC and CAR-T Cell Therapy for Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 18
Next Page